WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
SHANGHAI, July 21 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 200...
WuXi PharmaTech Receives Award from BASF
SHANGHAI, July 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that it had received an award from BASF for excellent service and outstanding contributions in the area of custom synthesis for new crop-protection active ingredients. (Logo: http://www.pr...
WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
SHANGHAI, June 29 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that it had been selected by China’s Ministry of Commerce to the list of Top Ten Leading Outsourcing Enterprises in China. The list was announced at the Second Annual China International Service Outso...
WuXi PharmaTech Files 2008 Annual Report on Form 20-F
SHANGHAI, June 26 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2008 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at http://...
WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
SHANGHAI, June 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Felix Hsu has been appointed Senior Vice ...
WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
SHANGHAI, June 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Wei-Min Chang has been appointed Vice Pre...
WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that Edward Hu, the Company’s Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009, at 1...
WuXi PharmaTech Announces First-Quarter 2009 Results
SHANGHAI, May 15 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results...
WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
SHANGHAI, May 5 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX) today announced that it has appointed Hao Zhou as Vice President of Finance. (Logo: http://www.prnasia.com/sa/2009/04/01/200904011147.jpg ) Prior to joining WuXi PharmaTech, Mr. Zhou worked for eleven years at Genera...
WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
Earnings Conference Call to be Held on May 15, 2009 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) SHANGHAI, May 4 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing compa...
WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection
SHANGHAI, March 31 /PRNewswire-Asia/ -- WuXi AppTec announced today that its Bioanalytical Services (BAS) unit had been inspected by the U.S. Food and Drug Administration (FDA) without the issuance of a Form 483, which is used to report any non compliance issues after a site inspection. (...
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
SHANGHAI, March 26 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial res...
Professor K. C. Nicolaou Speaks at WuXi AppTec
SHANGHAI, March 17 /PRNewswire-Asia/ -- WuXi AppTec is honored to have Prof. K. C. Nicolaou, the leading authority of the world on natural product total synthesis, as a WuXi AppTec Science Seminar Series lecturer to share his experience and expertise with our company’s scientists today. Total Sy...
WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
Earnings Conference Call to be Held on March 26, 2009 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) SHANGHAI, March 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing co...
WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
SHANGHAI, Feb. 17 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX) announced today that Benson Tsang, Chief Financial Officer, is leaving the company for personal reasons at the end of February. Edward Hu, Chief Operating Officer, will serve as acting Chief Financial Officer until a replacement ...
WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 list for the Fifth Consecutive Year
SHANGHAI, China, Feb. 9 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that it was selected for the Deloitte Technology...
WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
SHANGHAI, China, Feb. 6 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of Stewart Hen and Ning Zhao...
St. Paul and Atlanta Laboratories of WuXi PharmaTech (NYSE:WX) Receive ISO/IEC 17025:2005 Accreditation
SHANGHAI, China, Jan. 12 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its testing laboratories in St. Paul and Atlanta ...
WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
SHANGHAI, China, Jan. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Ge Li, the Company's Chairman a...
WuXi AppTec Selects H-Cube(R) from ThalesNano for Laboratory-based Hydrogenation
SHANGHAI, China, Dec. 23 /PRNewswire-Asia/ -- WuXi AppTec, the operating company of WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced its selection of...
